Tredje AP fonden Has $2.64 Million Stock Holdings in Baxter International Inc. (NYSE:BAX)

Tredje AP fonden lowered its position in shares of Baxter International Inc. (NYSE:BAX) by 1.6% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 78,931 shares of the medical instruments supplier’s stock after selling 1,246 shares during the quarter. Tredje AP fonden’s holdings in Baxter International were worth $2,640,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of BAX. Argent Trust Co raised its stake in Baxter International by 10.7% in the 2nd quarter. Argent Trust Co now owns 7,073 shares of the medical instruments supplier’s stock worth $237,000 after purchasing an additional 684 shares in the last quarter. Thompson Siegel & Walmsley LLC bought a new position in shares of Baxter International during the second quarter worth approximately $67,263,000. Stoneridge Investment Partners LLC bought a new position in shares of Baxter International during the second quarter worth approximately $1,319,000. Cornercap Investment Counsel Inc. raised its position in shares of Baxter International by 13.7% in the second quarter. Cornercap Investment Counsel Inc. now owns 54,912 shares of the medical instruments supplier’s stock valued at $1,837,000 after buying an additional 6,615 shares in the last quarter. Finally, LSV Asset Management bought a new stake in shares of Baxter International in the second quarter valued at approximately $140,296,000. Institutional investors own 90.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on BAX. Evercore ISI lowered their price objective on Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Citigroup dropped their price target on Baxter International from $38.00 to $37.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. Wells Fargo & Company reduced their price objective on shares of Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 7th. Morgan Stanley lowered shares of Baxter International from an “equal weight” rating to an “underweight” rating and decreased their target price for the company from $39.00 to $30.00 in a report on Monday, July 15th. Finally, StockNews.com raised shares of Baxter International from a “hold” rating to a “buy” rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $41.73.

Baxter International Stock Down 1.5 %

Baxter International stock opened at $38.76 on Friday. The firm has a 50 day moving average price of $36.95 and a two-hundred day moving average price of $37.43. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.91 and a current ratio of 1.40. Baxter International Inc. has a 52-week low of $31.01 and a 52-week high of $44.01. The firm has a market cap of $19.75 billion, a price-to-earnings ratio of 7.45, a PEG ratio of 1.33 and a beta of 0.59.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Tuesday, August 6th. The medical instruments supplier reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.02. The business had revenue of $3.81 billion for the quarter, compared to analysts’ expectations of $3.75 billion. Baxter International had a net margin of 16.51% and a return on equity of 18.06%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.55 earnings per share. Equities analysts predict that Baxter International Inc. will post 2.96 EPS for the current year.

Baxter International Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Friday, August 30th will be issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date of this dividend is Friday, August 30th. Baxter International’s payout ratio is 22.31%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.